Global Electroceuticals/Bioelectric Medicine Market Size Study, by Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators

Global Electroceuticals/Bioelectric Medicine Market Size Study, by Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Others), by Device Type (Implantable Devices, Non-invasive Devices), by Application (Arrhythmia, Sensorineural Hearing Loss, Epilepsy, Parkinson's Disease, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), and Regional Forecasts 2022-2032

The Global Electroceuticals/Bioelectric Medicine Market is valued at approximately USD 21.27 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.47% over the forecast period 2024-2032. Electroceuticals, which leverage electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes, are increasingly gaining traction as innovative solutions for various medical conditions. This non-pharmacological approach offers promising treatments for chronic pain, neurological disorders, and psychiatric conditions, thus driving market growth. The growing geriatric population, projected to reach 1.4 billion people aged 60 and over by 2030 according to the World Health Organization (WHO), is a pivotal driver of the electroceuticals market. This demographic shift highlights the increasing prevalence of cardiovascular disorders and Parkinson’s disease, necessitating advanced therapeutic technologies such as electroceuticals.

The market is also witnessing significant product innovation and regulatory support, fostering the availability of advanced electroceutical devices. For instance, the FDA approvals for Medtronic Plc's Micra AV and Boston Scientific's WaveWriter Alpha portfolio underscore the advancements in the field, bolstering market confidence and adoption. Additionally, the rise in minimally invasive procedures, government initiatives for medical device development, and advancements in healthcare technology further propel market growth. However, competition from pharmaceuticals and limited reimbursement policies pose challenges to market growth. Strategic positioning, advocating for improved reimbursement, and demonstrating cost-effectiveness are essential to overcoming these obstacles.

The key regions considered for the global electroceuticals/Bioelectric Medicine market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2022, attributed to well-established healthcare infrastructure, high healthcare spending, and extensive adoption of advanced therapeutic technologies. The region has a significant patient population suffering from chronic diseases such as cardiovascular disorders, neurological conditions, and chronic pain, which drive the demand for electroceutical therapies. Moreover, North America is home to numerous leading biotechnology and medical device companies that are actively involved in the research, development, and commercialization of electroceutical devices. Asia-Pacific is expected to exhibit the fastest growth during the forecast period, driven by robust economic development, expanding population, and improving healthcare infrastructure.

Major market players included in this report are:

Boston Scientific Corporation

Medtronic Plc

LivaNova PLC

Abbott Laboratories

Cochlear Limited

Biotronik SE & Co. KG

Nevro Corp.

Second Sight Medical Products, Inc.

Inspire Medical Systems, Inc.

ElectroCore, Inc.

MicroPort Scientific Corporation

NeuroPace, Inc.

Nuvectra Corporation

Axonics Modulation Technologies, Inc.

Mainstay Medical International plc

The detailed segments and sub-segment of the market are explained below:

By Product:

Cardiac Pacemakers & Implantable Cardioverter Defibrillators

Cochlear Implants

Spinal Cord Stimulators

Deep Brain Stimulators

Vagus Nerve Stimulators

Sacral Nerve Stimulators

Others

By Device Type:

Implantable Devices

Non-invasive Devices

By Application:

Arrhythmia

Sensorineural Hearing Loss

Epilepsy

Parkinson's Disease

Others

By End User:

Hospitals

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLATAM

Middle East & Africa

South Africa

Saudi Arabia

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.